跳至主要内容
临床试验/CTRI/2020/07/026593
CTRI/2020/07/026593已完成3 期

Pharmaco-therapeutic evaluation of Nagaphani( Opuntia elatior Mill.) fruit in Pandu with special reference to its efficacy in Cancer and Chemotherapy associated Anemia

Institute for Post Graduate Teaching and Research in Ayurveda1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年8月16日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Increase in Hb percentage

研究概览

简要总结

An open labeled randomized controlled clinical trial will be carried out to assess the efficacy of Nagaphani (Opuntia elatior Mill.) fruit juice in chemotherapy associated Anemia on a minimum of 30 patients in the dose of 40 ml per day orally before meal in two divided doses for a duration of 60 days and followup of 30 days  will be carried out along with conventional treatment protocol and compared with conventional group

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Any type of Cancer patients under Chemotherapy associated with Anemia Hb% below 12gm for female and below 13gm for male or reduced RBC count.

排除标准

  • Patient who are not under Chemotherapy Pregnancy and Lactation Severe Renal/Hepatic/Cardiac disease Any continuing blood loss Hemoglobin percentage below 6gm.

结局指标

主要结局

Increase in Hb percentage

时间窗: 60 days

次要结局

  • Increased RBC count(60 days)

研究者

发起方
Institute for Post Graduate Teaching and Research in Ayurveda
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验